Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK1 | Q15118 | 15/20 | 0.68 |
| ▸ | PDK2 | Q15119 | 15/20 | 0.68 |
| ▸ | PDK3 | Q15120 | 15/20 | 0.68 |
| ▸ | PDK4 | Q16654 | 15/20 | 0.68 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.65 |
| ▸ | ABCC9 | O60706 | 2/20 | 0.60 |
| ▸ | ABCC8 | Q09428 | 2/20 | 0.60 |
| ▸ | KCNJ11 | Q14654 | 2/20 | 0.60 |
| ▸ | KCNJ8 | Q15842 | 2/20 | 0.60 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.58 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.58 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4610340 | 0.90 | PDK1 (0.73) | PDK1PDK2PDK3PDK4ABCB11 | |
| SCHEMBL4609857 | 0.89 | PDK1 (0.74) | PDK1PDK2PDK3PDK4ABCB11 | |
| SCHEMBL4608406 | 0.89 | PDK1 (0.74) | PDK1PDK2PDK3PDK4ABCB11 | |
| SCHEMBL4609853 | 0.89 | PDK1 (0.74) | PDK1PDK2PDK3PDK4ABCB11 | |
| SCHEMBL6568128 | 0.88 | PDK1 (0.69) | PDK1PDK2PDK3PDK4ABCB11 | |
| SCHEMBL6568135 | 0.88 | PDK1 (0.69) | PDK1PDK2PDK3PDK4ABCB11 | |
| SCHEMBL6569679 | 0.88 | ABCC9 (0.72) | PDK1PDK2PDK3PDK4ABCB11 | |
| SCHEMBL6569622 | 0.88 | PDK1 (0.84) | PDK1PDK2PDK3PDK4ABCB11 | |
| SCHEMBL6569626 | 0.88 | PDK1 (0.84) | PDK1PDK2PDK3PDK4ABCB11 | |
| SCHEMBL4608283 | 0.88 | ABCC9 (0.72) | PDK1PDK2PDK3PDK4ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1976498-A2 | CHEMICAL COMPOUNDS | SmithKline Beecham Corporation (US) | 2008-10-08 | — | — | EP | claimed |
| WO-2007127505-A2 | USE OF SULFONAMIDE DERIVATIVES IN THE TREATMENT OF DISORDERS OF THE METABOLISM AND THE NERVOUS SYSTEM | SMITHKLINE BEECHAM CORPORATION (US) | 2007-11-08 | — | — | WO | claimed |
| EP-1976498-A2 | CHEMICAL COMPOUNDS | SmithKline Beecham Corporation (US) | 2008-10-08 | — | — | EP | disclosed |
| WO-2007127505-A2 | USE OF SULFONAMIDE DERIVATIVES IN THE TREATMENT OF DISORDERS OF THE METABOLISM AND THE NERVOUS SYSTEM | SMITHKLINE BEECHAM CORPORATION (US) | 2007-11-08 | — | — | WO | disclosed |